新華聯資本(00758.HK):集團仍繼續進行業務營運 繼續停牌
格隆匯5月13日丨新華聯資本(00758.HK)發佈公吿,於該公吿日期,公司正在與多方人士進行討論,以探討及考慮可供公司採納的不同選擇方案,以制訂可行的復牌建議,從而回應復牌指引。儘管公司股份停牌,然而,集團仍繼續進行其業務營運。
為證明其符合上市規則第13.24條的規定,集團一直在積極物色新合同,並繼續發展其現有業務,尤其是物業投資及物業發展業務。集團將會繼續物色具有良好潛力及前景的項目,以擴大集團的業務,按照聯交所信納的方式全面遵守上市規則,尋求儘快恢復公司股份買賣。公司股份暫停買賣,並將繼續停牌直至另行通知為止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.